In the early part of the 20th century, Serratia marcescens was considered a non-pathogenic organism and was used in medical experiments and as a biological warfare test agent [1]. Since the mid-1970s, however, Serratia species have been recognized to cause a full spectrum of human clinical disease. Additionally, Serratia species may harbor multidrug-resistance mechanisms that can complicate treatment decisions. This article will review the microbiology, epidemiology, clinical features, diagnosis, and treatment of infections caused by Serratia species.
Scar tissue is the formation of fibrosis connective tissue that is created to act as a protective barrier. It replaces healthy tissues that have been damaged due to a number of reasons. Scar tissue generally forms in muscles, tendons, ligaments, fascia, and joints. It is also called an adhesion.
Most of us take scarring for granted, knowing it is the bodyâs way of repairing damaged tissues. However, there is a down side to scars. Scar tissue shortens muscle tissue, which shows up as immobility, irritability and pain syndrome. The pain caused by scar tissue can also relate to trigger points that can be embedded in or around scars.